• Anagasta 20 mg gastro-resistant tablets

  Form: tablets, enteric-coated

  Active substance	Dosage
  PANTOPRAZOLE SODIUM SESQUIHYDRATE	22,6 mg

  ATC: A02B A02BC A02BC02

• Anagasta 40 mg gastro-resistant tablets

  Form: tablets, enteric-coated

  Active substance	Dosage
  PANTOPRAZOLE SODIUM SESQUIHYDRATE	45,10 mg

  ATC: A02B A02BC A02BC02

• Anagasta 40 mg powder for injection solution

  Form: powder for solution for injection

  Active substance	Dosage
  PANTOPRAZOLE SODIUM SESQUIHYDRATE	40 mg

  ATC: A02B A02BC A02BC02

• Pantecta 20 mg gastro-resistant tablets

  Form: tablets, enteric-coated

  Active substance	Dosage
  PANTOPRAZOLE SODIUM SESQUIHYDRATE	22,57 mg

  ATC: A02B A02BC A02BC02

• Pantecta 40 mg gastro-resistant tablets

  Form: tablets, enteric-coated

  Active substance	Dosage
  PANTOPRAZOLE SODIUM SESQUIHYDRATE	45,10 mg

  ATC: A02B A02BC A02BC02

• Qdenga powder and solvent for solution for injection in pre-filled syringe

  Form: powder and solvent for solution for injection

  Active substance	Dosage
  DENGUE VIRUS LIVE ATTENUATED SEROTYPE 1	≥ 3,3 log10 Unidades formadoras de placa/dosis (UFP/DOSIS)
  DENGUE VIRUS LIVE ATTENUATED SEROTYPE 2	≥ 2,7 log10 Unidades formadoras de placa/dosis (UFP/DOSIS)
  DENGUE VIRUS LIVE ATTENUATED SEROTYPE 3	≥ 4 log10 Unidades formadoras de placa/dosis (UFP/DOSIS)
  DENGUE VIRUS LIVE ATTENUATED SEROTYPE 4	≥ 4,5 log10 Unidades formadoras de placa/dosis (UFP/DOSIS)

  ATC: J07B J07BX J07BX04